These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38113962)

  • 1. Fas
    Bohat R; Liang X; Chen Y; Xu C; Zheng N; Guerrero A; Hou J; Jaffery R; Egan NA; Li Y; Tang Y; Unsal E; Robles A; Chen S; Major AM; Elldakli H; Chung SH; Liang H; Hicks MJ; Du Y; Lin JS; Chen X; Mohan C; Peng W
    Clin Immunol; 2024 Jan; 258():109874. PubMed ID: 38113962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity.
    Shi X; Xie C; Kreska D; Richardson JA; Mohan C
    J Exp Med; 2002 Aug; 196(3):281-92. PubMed ID: 12163557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of reciprocal Lmb1-4 interval MRL-Faslpr and C57BL/6-Faslpr congenic mice reveals significant effects from Lmb3.
    Santiago-Raber ML; Haraldsson MK; Theofilopoulos AN; Kono DH
    J Immunol; 2007 Jun; 178(12):8195-202. PubMed ID: 17548658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal thymic maturation and lymphoproliferation in MRL-Fas
    Ashman RF; Singh N; Lenert PS
    Lupus; 2017 Jun; 26(7):734-745. PubMed ID: 27837196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic dissection of systemic lupus erythematosus pathogenesis: partial functional complementation between Sle1 and Sle3/5 demonstrates requirement for intracellular coexpression for full phenotypic expression of lupus.
    Wakui M; Morel L; Butfiloski EJ; Kim C; Sobel ES
    J Immunol; 2005 Jul; 175(2):1337-45. PubMed ID: 16002739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune disease.
    Cauwe B; Martens E; Sagaert X; Dillen C; Geurts N; Li S; Mertens J; Thijs G; Van den Steen PE; Heremans H; De Vos R; Blockmans D; Arnold B; Opdenakker G
    J Autoimmun; 2011 May; 36(3-4):239-52. PubMed ID: 21376533
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Nagasu A; Mukai T; Iseki M; Kawahara K; Tsuji S; Nagasu H; Ueki Y; Ishihara K; Kashihara N; Morita Y
    Cells; 2019 Apr; 8(5):. PubMed ID: 31052273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 regulates murine lupus.
    Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J
    J Immunol; 2002 Aug; 169(4):2148-55. PubMed ID: 12165544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The centromeric region of chromosome 7 from MRL mice (Lmb3) is an epistatic modifier of Fas for autoimmune disease expression.
    Kong PL; Morel L; Croker BP; Craft J
    J Immunol; 2004 Mar; 172(5):2785-94. PubMed ID: 14978078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
    Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
    J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice.
    Corneth OBJ; Schaper F; Luk F; Asmawidjaja PS; Mus AMC; Horst G; Heeringa P; Hendriks RW; Westra J; Lubberts E
    Sci Rep; 2019 Mar; 9(1):4032. PubMed ID: 30858513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
    Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
    J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A signal adaptor SLAM-associated protein regulates spontaneous autoimmunity and Fas-dependent lymphoproliferation in MRL-Faslpr lupus mice.
    Komori H; Furukawa H; Mori S; Ito MR; Terada M; Zhang MC; Ishii N; Sakuma N; Nose M; Ono M
    J Immunol; 2006 Jan; 176(1):395-400. PubMed ID: 16365433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The major murine systemic lupus erythematosus susceptibility locus Sle1 results in abnormal functions of both B and T cells.
    Sobel ES; Satoh M; Chen Y; Wakeland EK; Morel L
    J Immunol; 2002 Sep; 169(5):2694-700. PubMed ID: 12193743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
    Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M
    Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2X7 purinergic receptor plays a critical role in maintaining T-cell homeostasis and preventing lupus pathogenesis.
    Mellouk A; Hutteau-Hamel T; Legrand J; Safya H; Benbijja M; Mercier-Nomé F; Benihoud K; Kanellopoulos JM; Bobé P
    Front Immunol; 2022; 13():957008. PubMed ID: 36248812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of stem cell antigen-1 (Ly-6A/E) in lymphocytes from lupus prone mice correlates with disease severity.
    Kumar KR; Zhu J; Bhaskarabhatla M; Yan M; Mohan C
    J Autoimmun; 2005 Nov; 25(3):215-22. PubMed ID: 16246522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.